Bellinda L. King‐Kallimanis
ORCID: 0000-0001-9418-9374Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Keith M. Bellizzi, Andrew Galligan, Bellinda L. King‐Kallimanis, Deborah K. Mayer, Christine Miaskowski +8 more
Papers
Driven by 8 papers — median percentile 29. Top paper: “FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer”.
Christy Osgood, Anup Amatya, Mallorie H. Fiero, C.J. George Chang, Tiffany K. Ricks +32 more
Keith M. Bellizzi, Andrew Galligan, Bellinda L. King‐Kallimanis, Deborah K. Mayer, Christine Miaskowski +8 more
Gina L. Mazza, Blake Langlais, Bellinda L. King‐Kallimanis, Lauren J. Rogak, Patient Tolerability Consortia Standardization Working Group +1 more
Samantha Cruz Rivera, Jessica Roydhouse, Paul Kamudoni, Yvonne Alder, Nicola Anderson +35 more
Olalekan Lee Aiyegbusi, Emily Alger, Ethan Basch, Jill A. Bell, Vishal Bhatnagar +27 more
Tatiana M. Prowell, Jennifer Gao, Laura L. Fernandes, Emily Li, Xiling Jiang +29 more
Melanie Calvert, Steven Rizk, Philip Collis, Alastair Greystoke, Bellinda L. King‐Kallimanis +27 more
Madeleine King, Rebecca Mercieca‐Bebber, Olalekan Lee Aiyegbusi, Derek Kyte, Anita Slade +41 more